Santhera Pharmaceuticals Holding Ag (0QN1)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
総売上 | 19.03M | 22.94M | 31.66M | 75.38M | 15.01M | -1.6M | 7.47M | 103.41M |
営業利益 | -33.13M | -50.45M | -51.42M | -10.44M | -53.08M | -56.89M | -51.98M | 51.16M |
税引前収入 | -33.19M | -51.28M | -53.86M | -18.39M | -67.46M | -54.72M | -70.62M | 54.82M |
純利益 | -35.42M | -51.53M | -54.19M | -18.97M | -67.66M | -55.53M | -71.08M | 54.78M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -5.643 | -8.207 | -5.081 | -1.699 | -3.732 | -1.12 | -0.944 | 4.842 |
EBIT | -33.13M | -50.45M | -51.42M | -10.44M | -53.08M | -56.89M | -51.98M | 68.84M |
EBITDA | -29.86M | -47.07M | -47.68M | -5.67M | -45.93M | -53.16M | -48.33M | 54.21M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約